Navigation Links
Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
Date:5/16/2011

inistration into the surgical wound clinical studies involving 823 patients; the most common adverse events following EXPAREL administration were nausea, constipation, and vomiting.

Forward Looking Statements

Any statements in this press release about our future expectations, plans and prospects, including statements about EXPAREL's potential, and other statements containing the words "believes," "anticipates," "plans," "expects," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks relating to: the timing of, and our ability to obtain regulatory approval of EXPAREL; the timing of our anticipated commercial launch of EXPAREL; the rate and degree of market acceptance of EXPAREL; the size and growth of the potential markets for EXPAREL and our ability to serve those markets; our commercialization and marketing capabilities; and other factors discussed in the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2010, and in other filings that we periodically make with the SEC. In addition, the forward-looking statements included in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Contacts:

James S. Scibetta
Chief Financial Officer
Pacira Pharmaceuticals, Inc.
(973) 254-3570

Dan Budwick
Vice President, Me
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
2. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations
3. Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call
4. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
5. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
6. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
7. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
8. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
9. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
10. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
11. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has announced the ... End-User & by Region - Global Trends & Forecast to ... is projected to reach about $2.5 Million by 2020, with ... opportunities in countries such as India , ... and Brazil . In 2013, the North ...
(Date:7/2/2015)... , July 2, 2015 Numotion,s Board of ... announced that Tamas Feitel has joined the ... Numotion after a highly successful 18 year career at ... driving strategy, profitability, and productivity to result in significant ... position was Chief Financial Officer for GE Healthcare Global ...
(Date:7/2/2015)... The report "Silage Inoculants & ... Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type & ... Inoculants & Enzymes Market is expected to reach $489.05 ... 2015 to 2020. Browse 75 market ... P ages and an in-depth TOC ...
Breaking Medicine Technology:Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Numotion Names Tamas Feitel Chief Financial Officer 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4
... Volcano Corporation (Nasdaq: VOLC ) stated today that it will vigorously ... Medical in federal district court in Delaware . Volcano believes that ... vindicating its rights in court. , ... The Complaint filed today has nothing to do with other ...
... 27 James M. Golubieski , president of Foundation ... UMDNJ affiliate, announced today that it has sold its equity interest ... , , ... , based company, is involved in developing kinase inhibitors that may ...
Cached Medicine Technology:Volcano Will Strongly Defend Against St. Jude Lawsuit 2Volcano Will Strongly Defend Against St. Jude Lawsuit 3Foundation Venture Capital Group Sells Interest in Longevica Pharmaceuticals 2Foundation Venture Capital Group Sells Interest in Longevica Pharmaceuticals 3Foundation Venture Capital Group Sells Interest in Longevica Pharmaceuticals 4
(Date:7/2/2015)... ... ... Enterprises, LLC. is pleased to announce the opening of its newest location in Dallas, Texas. ... premium frozen yogurt chain was listed as #22 on the Inc. 500 list of fastest ... Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX 75220 , ...
(Date:7/2/2015)... ... 02, 2015 , ... Following the recent report by JAMA Internal Medicine ... merely overweight Americans, Samir Becic emphatically declared a war on obesity in the United ... Becic said. "We must understand the magnitude of this discovery. For that reason, I ...
(Date:7/2/2015)... ... 2015 , ... When Walker Parking Consultants specified Kenall Manufacturing ... they knew it would save the university energy and maintenance costs. What they ... energy savings after installation was an impressive 89 percent, which resulted in the ...
(Date:7/2/2015)... ... ... in full swing, Americans are flocking to Canada’s many lakes to reel in their fair ... world, and it’s easy to understand why. From the Pacific Northwest Coast of British Columbia ... is a huge industry, and Americans make up the vast majority of anglers from outside ...
(Date:7/2/2015)... ... ... “ LIFX ” was featured on NewsWatch as part of its monthly Tech Report, ... technology expert and special reporter for NewsWatch, conducted the review and shared with viewers ... , According to the U.S. Department of Energy, it’s very important to use energy-efficient ...
Breaking Medicine News(10 mins):Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2
... of,National Children,s Dental Health Month (NCDHM) in February, ... poster,contest. All Pennsylvania third-grade students are eligible to ... will receive a $1,000 education bond and see ... distributed to all of,Pennsylvania,s public libraries. In addition ...
... apocynin almost doubles life span of mice with inherited ... -- A drug that nearly doubles the life span ... been identified by University of Iowa researchers, who made ... in the lab. , The study results, published online ...
... of Women,s ... Ovarian Reserve, COLORADO ... announced it will be the first IVF center,in the region to ... an assessment of a woman,s egg supply by combining,multiple factors including ...
... Jan. 24 RESMED INC. (NYSE: RMD ),announced ... release its,earnings for this second quarter of fiscal year ... press release after 1:00 p.m. Pacific,Time and will host ... and future outlook., The conference call is scheduled ...
... consumers on the use of Zetia and ... ... Shapiro filed,a proposed class-action lawsuit against Merck (NYSE: MRK ) and,Schering-Plough ... violated state consumer protection laws arising,from the sale and marketing of Zetia ...
... FRANCISCO, Calif., Jan. 24 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... initiate,an offering of 4,000,000 shares of common stock ... file with the,Securities And Exchange Commission. It is ... over-allotment option for an additional,600,000 shares., Credit ...
Cached Medicine News:Health News:Surprise in Lab Helps ID Drug to Fight ALS 2Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 2Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 3Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 4Health News:RESMED to Webcast Second Quarter 2008 Earnings Conference Call 2Health News:CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough 2Health News:CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough 3Health News:Rigel Announces Offering of 4,000,000 Shares of Common Stock 2
... combines efficient stone fragmentation, low purchase price, ... clear LED display, automatic probe sensing circuitry, ... probe size. In addition, the AEH-4 has ... can also regulate and control relative power ...
Electrohydraulic Lithotripsy Probe for AEH-4...
Short examining bridge for insertion of instruments...
Albarran double-horn bridge for use with sheaths from 20-25 Fr and designed for accurate articulation of flexible devices....
Medicine Products: